vs

Side-by-side financial comparison of Ardmore Shipping Corp (ASC) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.

NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $81.2M, roughly 1.5× Ardmore Shipping Corp). Ardmore Shipping Corp runs the higher net margin — 15.7% vs 3.3%, a 12.4% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -15.5%). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -6.0%).

Ardmore Shipping Corp is a global maritime transport company that owns and operates a fleet of mid-sized product and chemical tankers. It provides seaborne transport for petroleum products, specialty chemicals and bulk liquid commodities, serving energy, chemical and trading clients across key international trade routes.

Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.

ASC vs NATR — Head-to-Head

Bigger by revenue
NATR
NATR
1.5× larger
NATR
$123.8M
$81.2M
ASC
Growing faster (revenue YoY)
NATR
NATR
+20.2% gap
NATR
4.7%
-15.5%
ASC
Higher net margin
ASC
ASC
12.4% more per $
ASC
15.7%
3.3%
NATR
Faster 2-yr revenue CAGR
NATR
NATR
Annualised
NATR
5.6%
-6.0%
ASC

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASC
ASC
NATR
NATR
Revenue
$81.2M
$123.8M
Net Profit
$12.8M
$4.1M
Gross Margin
72.5%
Operating Margin
16.1%
4.3%
Net Margin
15.7%
3.3%
Revenue YoY
-15.5%
4.7%
Net Profit YoY
-47.0%
1379.4%
EPS (diluted)
$0.30
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASC
ASC
NATR
NATR
Q4 25
$123.8M
Q3 25
$81.2M
$128.3M
Q2 25
$72.0M
$114.8M
Q1 25
$74.0M
$113.2M
Q4 24
$118.2M
Q3 24
$96.1M
$114.6M
Q2 24
$121.3M
$110.6M
Q1 24
$106.3M
$111.0M
Net Profit
ASC
ASC
NATR
NATR
Q4 25
$4.1M
Q3 25
$12.8M
$5.3M
Q2 25
$9.6M
$5.3M
Q1 25
$6.3M
$4.7M
Q4 24
$-321.0K
Q3 24
$24.1M
$4.3M
Q2 24
$62.7M
$1.3M
Q1 24
$39.2M
$2.3M
Gross Margin
ASC
ASC
NATR
NATR
Q4 25
72.5%
Q3 25
73.3%
Q2 25
71.7%
Q1 25
72.1%
Q4 24
72.0%
Q3 24
71.3%
Q2 24
71.4%
Q1 24
71.2%
Operating Margin
ASC
ASC
NATR
NATR
Q4 25
4.3%
Q3 25
16.1%
7.0%
Q2 25
13.5%
3.7%
Q1 25
8.6%
5.4%
Q4 24
3.8%
Q3 24
25.4%
4.6%
Q2 24
51.3%
5.1%
Q1 24
37.2%
4.2%
Net Margin
ASC
ASC
NATR
NATR
Q4 25
3.3%
Q3 25
15.7%
4.2%
Q2 25
13.3%
4.6%
Q1 25
8.5%
4.2%
Q4 24
-0.3%
Q3 24
25.1%
3.8%
Q2 24
51.7%
1.2%
Q1 24
36.9%
2.1%
EPS (diluted)
ASC
ASC
NATR
NATR
Q4 25
$0.23
Q3 25
$0.30
$0.30
Q2 25
$0.22
$0.28
Q1 25
$0.14
$0.25
Q4 24
$-0.02
Q3 24
$0.55
$0.23
Q2 24
$1.47
$0.07
Q1 24
$0.92
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASC
ASC
NATR
NATR
Cash + ST InvestmentsLiquidity on hand
$93.9M
Total DebtLower is stronger
$116.1M
Stockholders' EquityBook value
$628.2M
$161.6M
Total Assets
$799.8M
$261.1M
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASC
ASC
NATR
NATR
Q4 25
$93.9M
Q3 25
$95.6M
Q2 25
$81.3M
Q1 25
$86.5M
Q4 24
$84.7M
Q3 24
$78.7M
Q2 24
$68.7M
Q1 24
$77.8M
Total Debt
ASC
ASC
NATR
NATR
Q4 25
Q3 25
$116.1M
Q2 25
$25.0M
Q1 25
$20.5M
Q4 24
Q3 24
$22.5M
Q2 24
$44.2M
Q1 24
$23.1M
$2.1M
Stockholders' Equity
ASC
ASC
NATR
NATR
Q4 25
$161.6M
Q3 25
$628.2M
$166.7M
Q2 25
$618.3M
$163.7M
Q1 25
$610.7M
$167.1M
Q4 24
$161.0M
Q3 24
$627.0M
$162.6M
Q2 24
$617.7M
$156.4M
Q1 24
$567.9M
$159.7M
Total Assets
ASC
ASC
NATR
NATR
Q4 25
$261.1M
Q3 25
$799.8M
$264.8M
Q2 25
$703.8M
$254.9M
Q1 25
$690.4M
$252.7M
Q4 24
$240.9M
Q3 24
$722.8M
$245.3M
Q2 24
$742.0M
$235.8M
Q1 24
$704.1M
$247.3M
Debt / Equity
ASC
ASC
NATR
NATR
Q4 25
Q3 25
0.18×
Q2 25
0.04×
Q1 25
0.03×
Q4 24
Q3 24
0.04×
Q2 24
0.07×
Q1 24
0.04×
0.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASC
ASC
NATR
NATR
Operating Cash FlowLast quarter
$17.9M
$9.9M
Free Cash FlowOCF − Capex
$7.6M
FCF MarginFCF / Revenue
6.1%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
1.40×
2.41×
TTM Free Cash FlowTrailing 4 quarters
$28.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASC
ASC
NATR
NATR
Q4 25
$9.9M
Q3 25
$17.9M
$18.5M
Q2 25
$11.2M
$4.3M
Q1 25
$26.3M
$2.6M
Q4 24
$12.2M
Q3 24
$39.9M
$9.6M
Q2 24
$48.4M
$1.3M
Q1 24
$49.2M
$2.2M
Free Cash Flow
ASC
ASC
NATR
NATR
Q4 25
$7.6M
Q3 25
$16.8M
Q2 25
$3.0M
Q1 25
$1.5M
Q4 24
$10.0M
Q3 24
$7.9M
Q2 24
$-2.0M
Q1 24
$-1.5M
FCF Margin
ASC
ASC
NATR
NATR
Q4 25
6.1%
Q3 25
13.1%
Q2 25
2.6%
Q1 25
1.3%
Q4 24
8.5%
Q3 24
6.9%
Q2 24
-1.9%
Q1 24
-1.4%
Capex Intensity
ASC
ASC
NATR
NATR
Q4 25
1.9%
Q3 25
1.3%
Q2 25
1.2%
Q1 25
1.0%
Q4 24
1.9%
Q3 24
1.5%
Q2 24
3.0%
Q1 24
3.3%
Cash Conversion
ASC
ASC
NATR
NATR
Q4 25
2.41×
Q3 25
1.40×
3.46×
Q2 25
1.17×
0.81×
Q1 25
4.20×
0.55×
Q4 24
Q3 24
1.65×
2.21×
Q2 24
0.77×
0.97×
Q1 24
1.25×
0.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASC
ASC

Segment breakdown not available.

NATR
NATR

Other$68.1M55%
General Health Products$20.2M16%
Digestive Products$13.8M11%
Cardiovascular Products$12.1M10%
Personal Care Products$4.4M4%
Immunity Products$3.1M3%
Weight Management Products$2.1M2%

Related Comparisons